| Financial Year |
March 31 2023 |
| Monetary Funds |
2,388,870,788.89 |
| Held-for-trading Financial Assets |
785,304,178.08 |
| Notes Receivable |
41,743,220.27 |
| Accounts Receivable |
1,210,126,798.75 |
| Advances to Suppliers |
95,246,567.59 |
| Other Receivables |
65,522,357.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
564,359,199.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
80,609,450.13 |
| Total Current Assets |
5,251,922,543.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
84,025,356.88 |
| Investment Properties |
28,222,447.13 |
| Fixed Assetes |
3,556,812,775.87 |
| Under-construction Projects |
592,945,501.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,679,976,321.48 |
| R&D expenses |
1,229,847.88 |
| Goodwill |
18,940,991.50 |
| Long-Term Deferred and Prepaid Expenses |
97,084,060.12 |
| Deferred Income Tax Assets |
156,778,796.86 |
| Other Non-Current Assets |
322,143,093.28 |
| Sub-Total of Non-Current Assets |
7,359,740,277.35 |
| Total Assets |
12,611,662,820.55 |
| Short-Term Loans |
1,058,664,968.08 |
| Trading Financial liabilities |
926,700.00 |
| Notes Payable |
46,182,119.72 |
| Accounts Payable |
1,123,252,635.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
188,572,962.40 |
| Taxes Payable |
257,933,207.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
386,499,354.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
195,849,775.45 |
| Other Current Liabilities |
700,454,866.40 |
| Sub-Total of Current Liabilities |
4,956,585,636.67 |
| Long-term Loans |
1,347,612,845.69 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,475,996.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,508,008,836.15 |
| Total Liabilities |
6,464,594,472.82 |
| Paid-In Capital(Or Share Stock) |
912,370,038.00 |
| Capital Surplus |
968,149,547.04 |
| Surplus Reserve |
523,449,300.26 |
| LESS:Treasury Stock |
99,999,002.64 |
| Undistributed Profits |
3,582,424,454.06 |
| Minority Stockholder's Interest |
261,028,343.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,886,040,004.59 |
| Owner's Equity（Stockholder's Equity） |
6,147,068,347.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,611,662,820.55 |
